Announced
Completed
Novo and Bioqube Ventures led an €11m investment in Commit Biologics.
Financials
Transaction Value£9m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Tags
Denmark
Cross Border
Minority
immunotherapy
Biotechnology
Private
Private Equity
Completed
Single Bidder
Acquisition
Venture Capital
Friendly
Synopsis
Novo, a life science investor, and Bioqube Ventures, a specialist life sciences investment firm, led an €11m investment in Commit Biologics, a biotech spin-out from Aarhus University.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.